Gilead Sciences Inc. said late Tuesday that it was appointing Kevin Young as chief operating officer. Young served for 10 years as Gilead's vice president of commerical operations and most recently has been a senior advisor to the biotech company. Gilead shares rose 0.2% to $86.35 after hours.
Continue Reading Below
Copyright © 2016 MarketWatch, Inc.